Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating consolidative local therapy for oligometastatic urothelial carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Locally Advanced Urothelial Carcinoma, Oligo-metastaic Urothelial Carcinoma | Phase 2 | Status: RECRUITING